1. Home
  2. ARQT vs TNL Comparison

ARQT vs TNL Comparison

Compare ARQT & TNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$29.51

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Logo Travel   Leisure Co. Common  Stock

TNL

Travel Leisure Co. Common Stock

HOLD

Current Price

$68.47

Market Cap

4.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARQT
TNL
Founded
2016
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
4.0B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ARQT
TNL
Price
$29.51
$68.47
Analyst Decision
Strong Buy
Buy
Analyst Count
7
10
Target Price
$24.83
$67.60
AVG Volume (30 Days)
2.3M
557.8K
Earning Date
10-28-2025
10-22-2025
Dividend Yield
N/A
3.28%
EPS Growth
N/A
3.11
EPS
N/A
6.07
Revenue
$317,929,000.00
$3,967,000,000.00
Revenue This Year
$85.51
$4.48
Revenue Next Year
$30.74
$4.31
P/E Ratio
N/A
$11.24
Revenue Growth
129.21
3.60
52 Week Low
$11.13
$37.77
52 Week High
$31.77
$70.43

Technical Indicators

Market Signals
Indicator
ARQT
TNL
Relative Strength Index (RSI) 59.80 62.99
Support Level $28.95 $67.40
Resistance Level $31.77 $68.88
Average True Range (ATR) 1.36 1.43
MACD -0.14 0.19
Stochastic Oscillator 54.51 88.57

Price Performance

Historical Comparison
ARQT
TNL

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About TNL Travel Leisure Co. Common Stock

Travel+Leisure Co is a membership and leisure travel company. It provides hospitality services and travel products. The company operates in the segments of Vacation Ownership, which is the key revenue-driving segment, develops, markets and sells vacation ownership interests (VOIs) to individual consumers, provides consumer financing in connection with the sale of VOIs, and provides property management services at resorts, and Travel and Membership which operates a variety of travel businesses, including three vacation exchange brands, a home exchange network, travel technology platforms, travel memberships, and direct-to-consumer rentals. The majority of the revenue is earned from the United States.

Share on Social Networks: